267 related articles for article (PubMed ID: 25864810)
1. Is Bax/Bcl-2 ratio considered as a prognostic marker with age and tumor location in colorectal cancer?
Khodapasand E; Jafarzadeh N; Farrokhi F; Kamalidehghan B; Houshmand M
Iran Biomed J; 2015; 19(2):69-75. PubMed ID: 25864810
[TBL] [Abstract][Full Text] [Related]
2. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
[TBL] [Abstract][Full Text] [Related]
3. IMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN CONVENTIONAL RENAL CELL CARCINOMA.
Saker Z; Tsintsadze O; Jiqia I; Managadze L; Chkhotua A
Georgian Med News; 2015 Dec; (249):27-33. PubMed ID: 26719546
[TBL] [Abstract][Full Text] [Related]
4. Expression of pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins in human retinoblastoma.
Singh L; Pushker N; Saini N; Sen S; Sharma A; Bakhshi S; Chawla B; Kashyap S
Clin Exp Ophthalmol; 2015 Apr; 43(3):259-67. PubMed ID: 25132102
[TBL] [Abstract][Full Text] [Related]
5. The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues.
Yao Q; Chen J; Lv Y; Wang T; Zhang J; Fan J; Wang L
Tumour Biol; 2011 Dec; 32(6):1163-71. PubMed ID: 21861179
[TBL] [Abstract][Full Text] [Related]
6. Bcl-XL protein levels determine apoptotic index in pancreatic carcinoma.
Sharma J; Srinivasan R; Majumdar S; Mir S; Radotra BD; Wig JD
Pancreas; 2005 May; 30(4):337-42. PubMed ID: 15841044
[TBL] [Abstract][Full Text] [Related]
7. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
8. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.
Gradilone A; Gazzaniga P; Ribuffo D; Scarpa S; Cigna E; Vasaturo F; Bottoni U; Innocenzi D; Calvieri S; Scuderi N; Frati L; Aglianò AM
J Clin Oncol; 2003 Jan; 21(2):306-12. PubMed ID: 12525523
[TBL] [Abstract][Full Text] [Related]
9. The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer.
Carberry S; D'Orsi B; Monsefi N; Salvucci M; Bacon O; Fay J; Rehm M; McNamara D; Kay EW; Prehn JHM
Cell Death Dis; 2018 Jan; 9(2):125. PubMed ID: 29374142
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional inactivation of p53, Bax, Bcl-2 and Mdm2 correlates with malignant transformation of the uterine cervix.
Soufla G; Baritaki S; Sifakis S; Zafiropoulos A; Spandidos DA
Int J Biol Markers; 2005; 20(1):18-27. PubMed ID: 15832769
[TBL] [Abstract][Full Text] [Related]
11. The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma.
Zhang MS; Hu AH; Qiu H; Xiong HH; Chen Y
Med Oncol; 2012 Jun; 29(2):928-32. PubMed ID: 21380782
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis inhibiting factor Bcl-xL might be the crucial member of the Bcl-2 gene family in colorectal cancer.
Maurer CA; Friess H; Bühler SS; Wahl BR; Graber H; Zimmermann A; Büchler MW
Dig Dis Sci; 1998 Dec; 43(12):2641-8. PubMed ID: 9881495
[TBL] [Abstract][Full Text] [Related]
13. IMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER.
Saker Z; Tsintsadze O; Jiqia I; Managadze L; Chkhotua A
Georgian Med News; 2015 Dec; (249):7-14. PubMed ID: 26719543
[TBL] [Abstract][Full Text] [Related]
14. Heterodimerization of Bcl-2 and Bcl-X(L) with Bax and Bad in colorectal cancer.
Hattori T; Ookawa N; Fujita R; Fukuchi K
Acta Oncol; 2000; 39(4):495-500. PubMed ID: 11041112
[TBL] [Abstract][Full Text] [Related]
15. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
17. Tumor characteristics, expressions of ERCC1, Bax, p53, IGF1R, Bcl2, Bcl2/Bax and prognostic factors for overall survival in patients with lung carcinoid.
Velinovic M; Jankovic R; Jovanovic D; Skodric Trifunovic V; Gavrilovic D; Stojsic J; Cavic M
J BUON; 2019; 24(1):256-266. PubMed ID: 30941978
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas.
Ogura E; Senzaki H; Yamamoto D; Yoshida R; Takada H; Hioki K; Tsubura A
Oncol Rep; 1999; 6(2):365-9. PubMed ID: 10023006
[TBL] [Abstract][Full Text] [Related]
19. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.
O'Driscoll L; Linehan R; M Kennedy S; Cronin D; Purcell R; Glynn S; W McDermott E; D Hill A; J O'Higgins N; Parkinson M; Clynes M
Cancer Lett; 2003 Nov; 201(2):225-36. PubMed ID: 14607338
[TBL] [Abstract][Full Text] [Related]
20. Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival.
Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Sulik M; Kmiec Z
Oncol Rep; 2017 Jul; 38(1):201-210. PubMed ID: 28586030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]